<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-91317" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Vitamin B12 (Cobalamin)</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Al Amin</surname>
            <given-names>A S M</given-names>
          </name>
          <aff>Bangabandhu Sheikh Mujib Medical University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gupta</surname>
            <given-names>Vikas</given-names>
          </name>
          <aff>Wellness Psychiatry P.C</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>A S M Al Amin declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Vikas Gupta declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>16</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-91317.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p content-type="pubmed-excerpt">Vitamin B12 (cobalamin) is an essential vitamin and medication used to manage and treat pernicious anemia, ileal resection, treatment of spinal cord myelopathy, and other conditions. This activity reviews the indications, action, and possible contraindications for cobalamin as a valuable agent. This activity will highlight the mechanism of action, adverse event profile, and other key factors (e.g., off-label uses, dosing, pharmacodynamics, pharmacokinetics, monitoring, relevant interactions) pertinent for members of the interprofessional team of patients with pernicious anemia, ileal resections, spinal cord lesions, and other related conditions.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the mechanism of action of cobalamin.</p></list-item><list-item><p>Outline the advantages of cobalamin therapy.</p></list-item><list-item><p>Summarize the monitoring required during cobalamin therapy.</p></list-item><list-item><p>Review how interprofessional strategies can optimize vitamin B12 intake in patients, whether for deficiency or as a nutritional supplement.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=91317&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=91317">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-91317.s2" sec-type="Indications">
        <title>Indications</title>
        <p>Cobalamin consists of four compounds with different&#x000a0;biological functions, although these molecules are chemically similar. Cobalamine&#x000a0;is a tetrapyrrolic corrin ring with&#x000a0;central cobalt moiety. Cyanocobalamin and hydroxocobalamin are synthetic forms of cobalamin, whereas&#x000a0;adenosylcobalamin (AdoCbl) and methylcobalamin have a biological activity to act as cofactors in enzymatic reactions that play a role in the synthesis of DNA, myelin, and fatty acids, which are vital for cell division and growth. The bioavailability of cyanocobalamin and hydroxocobalamin is different, has distinct&#x000a0;pharmacologic properties, and can be used according to approved standards in a particular country.<xref ref-type="bibr" rid="article-91317.r1">[1]</xref><xref ref-type="bibr" rid="article-91317.r2">[2]</xref><xref ref-type="bibr" rid="article-91317.r3">[3]</xref><xref ref-type="bibr" rid="article-91317.r4">[4]</xref><xref ref-type="bibr" rid="article-91317.r5">[5]</xref></p>
        <p>
<bold>FDA approved indications:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Pernicious anemia: Intrinsic factor of Castle deficiency due to autoantibody formation against parietal cells of the stomach, which results in decreased absorption of vitamin B12 through ileum.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Malabsorption: Impairment of vitamin B12 absorption.</p>
          </list-item>
          <list-item>
            <p>Atrophic gastritis: Intrinsic factor level decreases and leads to reduced absorption of vitamin B12.</p>
          </list-item>
          <list-item>
            <p>Chronic acid-reducing medication use: Chronic reduction of acid secretion decreases the release of bound vitamin B12 from the protein of food particles, so R factor&#x000a0;is unable to bind, and ultimately vitamin B12 absorption is reduced.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Long-term metformin use: May&#x000a0;correlate with reduced intestinal mobility or intestinal bacterial overgrowth that competes with vitamin B12 and decreases its absorption.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Total or partial gastrectomy: It reduces the level of the intrinsic factor of Castle needed for vitamin B12 absorption, so decreased intrinsic factor leads to decreased vitamin B12 absorption.<xref ref-type="bibr" rid="article-91317.r6">[6]</xref></p>
          </list-item>
          <list-item>
            <p>Small bowel bacteria overgrowth: Vitamin B12 is overused by bacteria leading to B12 deficiency.</p>
          </list-item>
          <list-item>
            <p>Diphyllobothrium latum infection: Competes with vitamin B12 for absorption through the intestine.</p>
          </list-item>
          <list-item>
            <p>Pancreatic insufficiency</p>
          </list-item>
          <list-item>
            <p>Helicobacter pylori infection</p>
          </list-item>
          <list-item>
            <p>Dietary deficiency of vitamin B12<xref ref-type="bibr" rid="article-91317.r2">[2]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Non-FDA approved indications:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Cyanide poisoning<xref ref-type="bibr" rid="article-91317.r7">[7]</xref></p>
          </list-item>
          <list-item>
            <p>Smoke inhalation</p>
          </list-item>
          <list-item>
            <p>Surgery-associated vasoplegia<xref ref-type="bibr" rid="article-91317.r8">[8]</xref></p>
          </list-item>
          <list-item>
            <p>Folic acid deficiency</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-91317.s3" sec-type="Mechanism of Action">
        <title>Mechanism of Action</title>
        <p>The oral formulation of cobalamin is absorbable through the intestine despite the absence of intrinsic factor of Castle.&#x000a0;Approximately 1.2% of vitamin B12 is absorbed passively without the help of intrinsic factor. If a patient receives the oral formulation at high doses, this passive absorption is sufficient to replenish vitamin B12 deficiency. If intrinsic factor is present in an adequate amount, then oral cobalamin is absorbed with the help of intrinsic factor.&#x000a0;When administering cobalamin parenterally, it bypasses the intestinal barrier, absorbs quickly by diffusion, and enters into the systemic circulation.<xref ref-type="bibr" rid="article-91317.r9">[9]</xref></p>
        <p>In the systemic circulation, cobalamin binds with a transporter protein termed&#x000a0;transcobalamin II (TCII) and enters into the tissue with the receptor of transcobalamin II. Cobalamin has many cellular effects with the greatest impact on new blood cell generation and neurological function.&#x000a0;At the cellular level, cobalamin act as a cofactor of two enzymatic reactions that involve methionine synthase and methyl- malonyl-co A mutase.</p>
        <p>Methionine synthase helps to convert homocysteine to methionine with the help of cobalamin, where methyl-THF converts to THF as a byproduct of this reaction, which helps DNA synthesis. Methionine is an amino acid that converts into&#x000a0;S-adenosylmethionine and participates in numerous methylation processes of cells. This methylation reaction&#x000a0;is necessary for the synthesis of many molecules such as&#x000a0;phospholipids, neurotransmitters, and&#x000a0;regulation of gene expression. If cobalamin is not present in sufficient amount, megaloblastic anemia occurs by inhibiting DNA synthesis due to the folate trap. Cobalamin (vitamin B12) in the form of adenosylcobalamin acts as a cofactor for enzyme&#x000a0;methyl- malonyl-co A mutase, which converts methyl malonyl CoA to succinyl CoA. Through this reaction, it helps to metabolize&#x000a0;odd chain fatty acids and&#x000a0;branch chain amino acids.<xref ref-type="bibr" rid="article-91317.r4">[4]</xref><xref ref-type="bibr" rid="article-91317.r5">[5]</xref><xref ref-type="bibr" rid="article-91317.r6">[6]</xref></p>
      </sec>
      <sec id="article-91317.s4" sec-type="Administration">
        <title>Administration</title>
        <p>Cobalamin can be administered orally or intramuscularly depending on the cause, presentation, and demands of the patients. A patient with severe cobalamin deficiency is treated initially by the intramuscular route. If the deficiency is less severe, then oral formulation is also helpful in replenishing the B12 level.&#x000a0;Intramuscular&#x000a0;cobalamin remains in two forms,&#x000a0;cyanocobalamin and hydroxocobalamin.&#x000a0;Cyanocobalamin requires conversion to metabolically active cobalamin, which is available in the United States,&#x000a0;whereas hydroxocobalamin&#x000a0;is the preferred agent in parts of Europe. In the United States, cobalamin injections are usually given 1 mg daily for 1st week of treatment, then once weekly in the following month, and then every month.<xref ref-type="bibr" rid="article-91317.r9">[9]</xref><xref ref-type="bibr" rid="article-91317.r10">[10]</xref><xref ref-type="bibr" rid="article-91317.r11">[11]</xref><xref ref-type="bibr" rid="article-91317.r12">[12]</xref></p>
        <p>Sublingual or nasal routes&#x000a0;are expensive and inadequately studied; hence these routes cannot be recommended.<xref ref-type="bibr" rid="article-91317.r10">[10]</xref></p>
        <p>If cobalamin deficiency develops due to a strict vegan diet, oral formulation is enough in this case. High-dose oral cobalamin is also sufficient to replenish the B12 level absorbed through passive absorption or if the patient refuses to take injections. Oral daily 1-2mg of cobalamin seems to be suitable in these scenarios. The benefits of oral therapy include patient compliance, cost-effectiveness, as well as to reduce the bleeding risk in a patient taking anticoagulation.<xref ref-type="bibr" rid="article-91317.r5">[5]</xref><xref ref-type="bibr" rid="article-91317.r9">[9]</xref><xref ref-type="bibr" rid="article-91317.r13">[13]</xref><xref ref-type="bibr" rid="article-91317.r14">[14]</xref></p>
        <p>If a patient receives a diagnosis of pernicious anemia, then treatment should be for life. If there are other causes rather than pernicious anemia, treatment should continue until hematological indices improve.<xref ref-type="bibr" rid="article-91317.r14">[14]</xref></p>
        <p>Due to cobalamin sensitivity, an intradermal test is necessary before any parenteral treatment. Because of the tendency to develop anaphylaxis, cobalamin administration is never via the intravenous route.<xref ref-type="bibr" rid="article-91317.r15">[15]</xref></p>
      </sec>
      <sec id="article-91317.s5" sec-type="Adverse Effects">
        <title>Adverse Effects</title>
        <p>Significant pain is the common adverse effect of intramuscular vitamin B12, especially in thin people. Injectable cobalamin may also cause bleeding if the patient is taking anticoagulants. Although allergic reactions rarely happen, they can cause life-threatening anaphylaxis.&#x000a0;Injections are more allergenic than pills, and hydroxocobalamin&#x000a0;seems to be more allergenic than cyanocobalamin, although reactions can occur with all cobalamin forms.&#x000a0;Management options for allergic reactions include desensitization, antihistamines, and steroids.<xref ref-type="bibr" rid="article-91317.r9">[9]</xref><xref ref-type="bibr" rid="article-91317.r10">[10]</xref></p>
        <p>Other common adverse effects are fever, itching or rash, tingling or numbness of joint, shortness of breath, rapid weight gain, polycythemia, hypokalemia, congestive heart failure, pulmonary edema, and vascular thrombosis.&#x000a0;</p>
      </sec>
      <sec id="article-91317.s6" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>Anaphylaxis can occur due to sensitivity to the cobalt moiety or cobalamin molecule.&#x000a0;</p>
        <p>Cyanocobalamin should be used cautiously in patients with&#x000a0;Leber optic nerve atrophy because it can&#x000a0;increase disease severity. Cautious use is also recommended in renal failure due to the presence of the aluminum component in cyanocobalamin.&#x000a0;</p>
      </sec>
      <sec id="article-91317.s7" sec-type="Monitoring">
        <title>Monitoring</title>
        <p>Before&#x000a0;treatment with&#x000a0;cobalamin, the physician should evaluate the patient with some investigations, including serum vitamin B12, folate, iron, hematocrit, and reticulocyte count. Effective therapy may quickly reverse the laboratory abnormality within 24 hours and reestablish normal bone marrow hematopoiesis within 48 hours.&#x000a0;The reticulocyte count may increase after 3&#x000a0;to 4 days&#x000a0;and reaches its peak level after one week. A complete&#x000a0;blood count may become normal approximately within eight weeks.&#x000a0;Compliance with cobalamin supplementation should be monitored in vitamin B12 deficient patients. If the homocysteine or methylmalonic acid level fails to return to a normal level during the first week of treatment, it is suspicious for an incorrect diagnosis.<xref ref-type="bibr" rid="article-91317.r10">[10]</xref><xref ref-type="bibr" rid="article-91317.r13">[13]</xref></p>
        <p>Evidence of neuropsychiatric improvement varies according to the severity of symptoms and the level of vitamin deficiency. Usually, neurologic manifestations begin to improve within the first week of treatment, and it takes&#x000a0;six weeks to three months for complete recovery, although&#x000a0;residual neurological abnormalities may persist. Patients with delayed improvement, especially with gait, urinary, or bowel dysfunction,&#x000a0;should be offered rehabilitative therapy.<xref ref-type="bibr" rid="article-91317.r10">[10]</xref><xref ref-type="bibr" rid="article-91317.r13">[13]</xref></p>
        <p>Erythropoiesis significantly increases after treatment with cobalamin that may lead to hypokalemia. Thrombocytosis may occur after anemia correction. So, platelet count and serum potassium level require monitoring during cobalamin therapy.&#x000a0;</p>
        <p>Therapeutic response to cobalamin may be less in some patients with renal insufficiency, diabetes mellitus, elderly age, bone marrow suppressants use like chloramphenicol, infection,&#x000a0;and concomitant iron or folate deficiency.<xref ref-type="bibr" rid="article-91317.r16">[16]</xref>&#x000a0;So, regular monitoring should be done frequently in these conditions.</p>
        <p>Folate supplementation is necessary if the patient has concomitant folate deficiency, but folate treatment in a patient with vitamin B12 deficiency may cause irreversible neurological symptoms because folic acid can aggravate vitamin B12 deficiency. That is why folic acid and cobalamine should not be prescribed concomitantly in a patient with suspected vitamin B12 deficiency.<xref ref-type="bibr" rid="article-91317.r2">[2]</xref>&#x000a0;It is well-known that folate therapy may mask anemia, and not giving cobalamin treatment may accelerate neurologic damage in people with vitamin B&#x000a0;deficiency.<xref ref-type="bibr" rid="article-91317.r17">[17]</xref></p>
      </sec>
      <sec id="article-91317.s8" sec-type="Toxicity">
        <title>Toxicity</title>
        <p>Usually,&#x000a0;cobalamin toxicity or overdose does not occur, and there is no antidote for&#x000a0;cobalamin.&#x000a0;</p>
      </sec>
      <sec id="article-91317.s9" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Cobalamin (vitamin B12) deficiency may&#x000a0;result in different types of presentation and should be managed&#x000a0;with a holistic approach. An interprofessional healthcare team approach is needed, including clinicians, nurses, pharmacists, dieticians, and nutritionists. Early diagnosis and treatment are very much crucial as they may progress into irreversible neurological damage. Specialists involvement is necessary for several instances, such as:</p>
        <list list-type="bullet">
          <list-item>
            <p>A&#x000a0;gastroenterologist or a GI surgeon should be a part of the healthcare team because many intestinal diseases cause&#x000a0;cobalamin deficiency.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Oncology follow-up may be needed as bowel, or pancreatic malignancy can cause cobalamin deficiency.</p>
          </list-item>
          <list-item>
            <p>A dietician or a nutritionist is also part of these patients as a dietary deficiency can cause cobalamin deficiency.&#x000a0;</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">D. latum</italic> infection can cause&#x000a0;cobalamin deficiency; therefore,&#x000a0;follow-up may be necessary with infectious disease specialists.</p>
          </list-item>
          <list-item>
            <p>Concomitant iron deficiency anemia or reduced potassium level may present during treatment so that hematologists may guide further treatment of these conditions.</p>
          </list-item>
        </list>
        <p>Clinicians should be aware of possible adverse effects, such as allergy and anaphylaxis. So precautions should be taken, and the intradermal test is necessary if an allergy is suspected. Patients should be educated about the disease and management because some patients may discontinue cobalamin once they feel better.<xref ref-type="bibr" rid="article-91317.r10">[10]</xref></p>
        <p>A physician is responsible for the diagnosis, evaluation, proper treatment, and&#x000a0;tailor therapy of patients for an individual basis. Given the array of causes for vitamin B-12 (cobalamin) deficiency, interprofessional collaboration is often required for diagnosis, treatment, and improving patient outcomes with this condition. [Level 5]</p>
      </sec>
      <sec id="article-91317.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=91317&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=91317">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/91317/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=91317">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-91317.s11">
        <title>References</title>
        <ref id="article-91317.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rizzo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lagan&#x000e0;</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Rapisarda</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>La Ferrera</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Buscema</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rossetti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Nigro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Muscia</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Valenti</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sapia</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sarpietro</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zigarelli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vitale</surname>
                <given-names>SG</given-names>
              </name>
            </person-group>
            <article-title>Vitamin B12 among Vegetarians: Status, Assessment and Supplementation.</article-title>
            <source>Nutrients</source>
            <year>2016</year>
            <month>Nov</month>
            <day>29</day>
            <volume>8</volume>
            <issue>12</issue>
            <pub-id pub-id-type="pmid">27916823</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91317.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Herrmann</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Obeid</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Cobalamin deficiency.</article-title>
            <source>Subcell Biochem</source>
            <year>2012</year>
            <volume>56</volume>
            <fpage>301</fpage>
            <page-range>301-22</page-range>
            <pub-id pub-id-type="pmid">22116706</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91317.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Markle</surname>
                <given-names>HV</given-names>
              </name>
            </person-group>
            <article-title>Cobalamin.</article-title>
            <source>Crit Rev Clin Lab Sci</source>
            <year>1996</year>
            <volume>33</volume>
            <issue>4</issue>
            <fpage>247</fpage>
            <page-range>247-356</page-range>
            <pub-id pub-id-type="pmid">8875026</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91317.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oh</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>DL</given-names>
              </name>
            </person-group>
            <article-title>Vitamin B12 deficiency.</article-title>
            <source>Am Fam Physician</source>
            <year>2003</year>
            <month>Mar</month>
            <day>01</day>
            <volume>67</volume>
            <issue>5</issue>
            <fpage>979</fpage>
            <page-range>979-86</page-range>
            <pub-id pub-id-type="pmid">12643357</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91317.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stover</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Vitamin B12 and older adults.</article-title>
            <source>Curr Opin Clin Nutr Metab Care</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>24</fpage>
            <page-range>24-7</page-range>
            <pub-id pub-id-type="pmid">19904199</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91317.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>O'Leary</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Samman</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Vitamin B12 in health and disease.</article-title>
            <source>Nutrients</source>
            <year>2010</year>
            <month>Mar</month>
            <volume>2</volume>
            <issue>3</issue>
            <fpage>299</fpage>
            <page-range>299-316</page-range>
            <pub-id pub-id-type="pmid">22254022</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91317.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fortin</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Waroux</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Giocanti</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Capellier</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ruttimann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kowalski</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Hydroxocobalamin for poisoning caused by ingestion of potassium cyanide: a case study.</article-title>
            <source>J Emerg Med</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>39</volume>
            <issue>3</issue>
            <fpage>320</fpage>
            <page-range>320-4</page-range>
            <pub-id pub-id-type="pmid">18554843</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91317.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Charles</surname>
                <given-names>FG</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Giordano</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Spiess</surname>
                <given-names>BD</given-names>
              </name>
            </person-group>
            <article-title>Vitamin B12 for the treatment of vasoplegia in cardiac surgery and liver transplantation: a narrative review of cases and potential biochemical mechanisms.</article-title>
            <source>Can J Anaesth</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>66</volume>
            <issue>12</issue>
            <fpage>1501</fpage>
            <page-range>1501-1513</page-range>
            <pub-id pub-id-type="pmid">31346957</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91317.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Qin</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Vidal-Alaball</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>TH</given-names>
              </name>
            </person-group>
            <article-title>Oral vitamin B<sub>12</sub> versus intramuscular vitamin B<sub>12</sub> for vitamin B<sub>12</sub> deficiency.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2018</year>
            <month>Mar</month>
            <day>15</day>
            <volume>3</volume>
            <issue>3</issue>
            <fpage>CD004655</fpage>
            <pub-id pub-id-type="pmid">29543316</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91317.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carmel</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>How I treat cobalamin (vitamin B12) deficiency.</article-title>
            <source>Blood</source>
            <year>2008</year>
            <month>Sep</month>
            <day>15</day>
            <volume>112</volume>
            <issue>6</issue>
            <fpage>2214</fpage>
            <page-range>2214-21</page-range>
            <pub-id pub-id-type="pmid">18606874</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91317.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Herrmann</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Obeid</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Causes and early diagnosis of vitamin B12 deficiency.</article-title>
            <source>Dtsch Arztebl Int</source>
            <year>2008</year>
            <month>Oct</month>
            <volume>105</volume>
            <issue>40</issue>
            <fpage>680</fpage>
            <page-range>680-5</page-range>
            <pub-id pub-id-type="pmid">19623286</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91317.r12">
          <label>12</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Vasavada</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sanghavi</surname>
                <given-names>DK</given-names>
              </name>
            </person-group>
            <chapter-title>Cyanocobalamin</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>1</month>
            <day>31</day>
            <pub-id pub-id-type="pmid">32310424</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91317.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Briani</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dalla Torre</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Citton</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Manara</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pompanin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Binotto</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Adami</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Cobalamin deficiency: clinical picture and radiological findings.</article-title>
            <source>Nutrients</source>
            <year>2013</year>
            <month>Nov</month>
            <day>15</day>
            <volume>5</volume>
            <issue>11</issue>
            <fpage>4521</fpage>
            <page-range>4521-39</page-range>
            <pub-id pub-id-type="pmid">24248213</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91317.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shipton</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Thachil</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Vitamin B12 deficiency - A 21st century perspective&#x02002;.</article-title>
            <source>Clin Med (Lond)</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>15</volume>
            <issue>2</issue>
            <fpage>145</fpage>
            <page-range>145-50</page-range>
            <pub-id pub-id-type="pmid">25824066</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91317.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Picksak</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Luft</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Stichtenoth</surname>
                <given-names>DO</given-names>
              </name>
            </person-group>
            <article-title>[Allergic reaction after intravenous application of vitamin B12].</article-title>
            <source>Med Monatsschr Pharm</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>33</volume>
            <issue>2</issue>
            <fpage>57</fpage>
            <page-range>57-8</page-range>
            <pub-id pub-id-type="pmid">20184264</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91317.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Solomon</surname>
                <given-names>LR</given-names>
              </name>
            </person-group>
            <article-title>Disorders of cobalamin (vitamin B12) metabolism: emerging concepts in pathophysiology, diagnosis and treatment.</article-title>
            <source>Blood Rev</source>
            <year>2007</year>
            <month>May</month>
            <volume>21</volume>
            <issue>3</issue>
            <fpage>113</fpage>
            <page-range>113-30</page-range>
            <pub-id pub-id-type="pmid">16814909</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91317.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dickinson</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Does folic acid harm people with vitamin B12 deficiency?</article-title>
            <source>QJM</source>
            <year>1995</year>
            <month>May</month>
            <volume>88</volume>
            <issue>5</issue>
            <fpage>357</fpage>
            <page-range>357-64</page-range>
            <pub-id pub-id-type="pmid">7796091</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
